Fingerprint
Dive into the research topics of 'Effect of nivolumab vs bevacizumab in patients with recurrent glioblastoma : the CheckMate 143 phase 3 randomized clinical trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Effect of nivolumab vs bevacizumab in patients with recurrent glioblastoma : the CheckMate 143 phase 3 randomized clinical trial
David A. Reardon, Alba A. Brandes, Antonio Omuro, Paul Mulholland, Michael Lim, Antje Wick, Joachim Baehring, Manmeet S. Ahluwalia, Patrick Roth, Oliver Bähr, Surasak Phuphanich, Juan Manuel Sepulveda, Paul De Souza, Solmaz Sahebjam, Michael Carleton, Kay Tatsuoka, Corina Taitt, Ricardo Zwirtes, John Sampson, Michael Weller
Research output: Contribution to journal › Article › peer-review